Nearly one in five patients receiving a GLP-1 medication reported experiencing food insecurity within the past year. Food insecurity was more frequently reported among patients who were dispensed GLP-1 medications for diabetes (20.5%) than among those who were dispensed GLP-1 medications for obesity (13.4%). A history of alcohol use was reported by nearly two-thirds (65.4%) of patients, while a history of tobacco use was reported by one in six (16.5%).